190 related articles for article (PubMed ID: 36735899)
1. Impact of the COVID-19 Pandemic on Cancer Screening Delays.
Zhang X; Elsaid MI; DeGraffinreid C; Champion VL; Paskett ED;
J Clin Oncol; 2023 Jun; 41(17):3194-3202. PubMed ID: 36735899
[TBL] [Abstract][Full Text] [Related]
2. Persistent Disparities in Cervical Cancer Screening Uptake: Knowledge and Sociodemographic Determinants of Papanicolaou and Human Papillomavirus Testing Among Women in the United States.
Johnson NL; Head KJ; Scott SF; Zimet GD
Public Health Rep; 2020; 135(4):483-491. PubMed ID: 32516053
[TBL] [Abstract][Full Text] [Related]
3. Changes in Health Care Access and Preventive Health Screenings by Race and Ethnicity.
Alba C; Zheng Z; Wadhera RK
JAMA Health Forum; 2024 Feb; 5(2):e235058. PubMed ID: 38306093
[TBL] [Abstract][Full Text] [Related]
4. Differences in cervical cancer screening and follow-up for black and white women in the United States.
Ford S; Tarraf W; Williams KP; Roman LA; Leach R
Gynecol Oncol; 2021 Feb; 160(2):369-374. PubMed ID: 33323276
[TBL] [Abstract][Full Text] [Related]
5. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
[No Abstract] [Full Text] [Related]
6. Racial and ethnic disparities in cervical and breast cancer screenings by nativity and length of U.S. residence.
La Frinere-Sandoval QNNB; Cubbin C; DiNitto DM
Ethn Health; 2023 Aug; 28(6):895-911. PubMed ID: 36774194
[TBL] [Abstract][Full Text] [Related]
7. Rural-urban disparities in preventive breast and cervical cancer screening among women with early-onset dementia.
Xu WY; Raver E; Jung J; Li Y; Thai G; Lee S
BMC Womens Health; 2023 May; 23(1):255. PubMed ID: 37170251
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Disability and Social Determinants of Health on Breast and Cervical Cancer Screenings During the COVID-19 Pandemic.
Rolle LD; Chery MJ; Larson M; Lopez-Pentecost M; Calfa CJ; Schlumbrecht MP; Crane TE
Prev Chronic Dis; 2024 Jan; 21():E05. PubMed ID: 38271492
[TBL] [Abstract][Full Text] [Related]
9. Pan-Canadian survey on the impact of the COVID-19 pandemic on cervical cancer screening and management: cross-sectional survey of healthcare professionals.
El-Zein M; Ali R; Farah E; Botting-Provost S; Franco EL;
Elife; 2023 Jun; 12():. PubMed ID: 37377399
[TBL] [Abstract][Full Text] [Related]
10. A population-based survey of self-reported delays in breast, cervical, colorectal and lung cancer screening.
Gunn CM; Berrian K; Weiss JE; Tosteson AAN; Hasson RM; Di Florio-Alexander R; Peacock JL; Rees JR
Prev Med; 2023 Oct; 175():107649. PubMed ID: 37517458
[TBL] [Abstract][Full Text] [Related]
11. Contextual analysis of breast and cervical cancer screening and factors associated with health care access among United States women, 2002.
Coughlin SS; Leadbetter S; Richards T; Sabatino SA
Soc Sci Med; 2008 Jan; 66(2):260-75. PubMed ID: 18022299
[TBL] [Abstract][Full Text] [Related]
12. Assessment of US Preventive Services Task Force Guideline-Concordant Cervical Cancer Screening Rates and Reasons for Underscreening by Age, Race and Ethnicity, Sexual Orientation, Rurality, and Insurance, 2005 to 2019.
Suk R; Hong YR; Rajan SS; Xie Z; Zhu Y; Spencer JC
JAMA Netw Open; 2022 Jan; 5(1):e2143582. PubMed ID: 35040970
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing.
Howell LP; Gurusinghe S; Tabnak F; Sciortino S
Cancer Detect Prev; 2009; 32(5-6):372-9. PubMed ID: 19264426
[TBL] [Abstract][Full Text] [Related]
14. An Evaluation of Breast and Cervical Cancer Screening Outcomes in an Education and Patient Navigation Program in Rural and Border Texas.
Falk D; Foley K; Weaver KE; Jones B; Cubbin C
J Cancer Educ; 2022 Aug; 37(4):1043-1052. PubMed ID: 33150556
[TBL] [Abstract][Full Text] [Related]
15. Effect of number of human papillomavirus vaccine doses on guideline adherent cervical cytology screening among 19-26year old females.
Hirth JM; Lin YL; Kuo YF; Berenson AB
Prev Med; 2016 Jul; 88():134-9. PubMed ID: 27085993
[TBL] [Abstract][Full Text] [Related]
16. Community-Based Screening for Cervical Cancer: A Feasibility Study of Rural Appalachian Women.
Crosby RA; Hagensee ME; Vanderpool R; Nelson N; Parrish A; Collins T; Jones N
Sex Transm Dis; 2015 Nov; 42(11):607-11. PubMed ID: 26462184
[TBL] [Abstract][Full Text] [Related]
17. Determinants of Potentially Unnecessary Cervical Cancer Screenings in American Women.
Seo M; Langabeer II JR
J Prev Med Public Health; 2018 Jul; 51(4):181-187. PubMed ID: 30071705
[TBL] [Abstract][Full Text] [Related]
18. County-Level Poverty and Barriers to Breast and Cervical Cancer Screening in a Health Education and Patient Navigation Program for Rural and Border Texas Residents.
Falk D; Cubbin C; Jones B
J Cancer Educ; 2022 Apr; 37(2):421-429. PubMed ID: 32696337
[TBL] [Abstract][Full Text] [Related]
19. Increasing Breast and Cervical Cancer Screening in Rural and Border Texas with Friend to Friend Plus Patient Navigation.
Falk D; Cubbin C; Jones B; Carrillo-Kappus K; Crocker A; Rice C
J Cancer Educ; 2018 Aug; 33(4):798-805. PubMed ID: 27900660
[TBL] [Abstract][Full Text] [Related]
20. Racial/Ethnic Differences Affecting Adherence to Cancer Screening Guidelines Among Women.
Hirth JM; Laz TH; Rahman M; Berenson AB
J Womens Health (Larchmt); 2016 Apr; 25(4):371-80. PubMed ID: 26579735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
